Table 1.
Characteristic | Category | No. of Cases | % of Cases |
---|---|---|---|
Age | 20–29 | 1 | 1.4 |
30–39 | 11 | 15.9 | |
40–49 | 18 | 26.1 | |
50–59 | 26 | 37.7 | |
60–69 | 9 | 13.0 | |
70–79 | 4 | 5.8 | |
Race | Asian | 2 | 2.9 |
African American | 5 | 7.2 | |
Hispanic | 9 | 13.0 | |
White | 53 | 76.8 | |
Performance Status | 0 | 47 | 68.1 |
1 or 2 | 22 | 31.9 | |
Cell Type | Adenocarcinoma, Unsp. | 21 | 30.4 |
Clear Cell Carcinoma | 1 | 1.4 | |
Adenosquamous | 5 | 7.2 | |
Squamous Cell Carcinoma | 41 | 59.4 | |
Mucinous Adenocarcinoma | 1 | 1.4 | |
Grade | 1: Well differentiated | 6 | 8.7 |
2: Moderately differentiated | 34 | 49.3 | |
3: Poorly differentiated | 29 | 42.0 | |
Prior Platinum | No | 25 | 36.0 |
Yes | 44 | 64.0 | |
Prior Radiation | No | 13 | 18.8 |
Yes | 56 | 81.2 | |
Prior Surgery | No | 48 | 69.6 |
Yes | 21 | 30.4 | |
Disease Status | ADV | 13 | 18.8 |
RCL | 26 | 37.7 | |
RCS | 30 | 43.5 | |
Prior Cis-RT | No | 25 | 36.2 |
Yes | 44 | 63.8 |